Research Article
Pathfast Presepsin Assay for Early Diagnosis of Systemic Inflammatory Response Syndrome in Patients with Nephrolithiasis
Table 3
Diagnostic performance of biomarkers in nephrolithiasis with SIRS patients.
| | | Presepsin (pg/mL) | PCT (ng/mL) | CRP (mg/mL) |
| | AUC (95% CI) | 84.6 (79.8~87.1) | 79.6 (75.3–82.5) | 71.8 (68.7~73.9) | | Cutoff | 389 | 0.641 | 11.3 | | Sensitivity (95% CI) | 74.7 (67.1–78.5) | 72.6 (62.8–76.4) | 70.7 (66.9–73.6) | | Specificity (95% CI) | 88.4 (80.2–92.6) | 85.3 (82.7–89.1) | 75.2 (71.5–80.2) |
|
|
CI: confidence intervals.
|
